Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/76126
Título
Reversal of Diabesity Through Modulating Sympathetic Inputs to Adipose Tissue Following Carotid Body Resection
Autor
Año del Documento
2025
Editorial
John Wiley & Sons Ltd.
Descripción
Producción Científica
Documento Fuente
Acta physiologica (Oxford, England), Julio 2025, vol. 241, n. 7, e70074
Zusammenfassung
Background and aims: The development of innovative strategies to treat diabesity and its comorbidities is of major societal importance. The carotid bodies (CB), classically defined as O2 sensors, are also metabolic sensors whose dysfunction contributes to the genesis and progression of metabolic disturbances. Here, we tested the hypothesis that the CBs are key players in the neural hypothalamic-sympathetic circuit controlling glucose and energy homeostasis. Moreover, we investigated if abolishment of CB activity has an anti-diabesity effect in Wistar rats and C75BL/6J mice, associated with increased visceral white and brown adipose tissue (AT) metabolism and the restoration of sympathetic activity within these tissues.
Results: We demonstrate that resection of the carotid sinus nerve, the CB-sensitive nerve, promotes weight loss and restores metabolic function in obese rats and mice by enhancing tyrosine hydroxylase expression at the paraventricular nucleus of the hypothalamus and its efferent sympathetic neurons to the AT. Moreover, we found that CSN resection increases sympathetic integration and catecholaminergic action in the AT in a manner that restores or even increases AT metabolism.
Conclusion: We provide groundbreaking and innovative data showing a new circuit involving the CB-hypothalamus-sympathetic efferents and the AT in controlling glucose and energy homeostasis and so a novel pathway for managing diabesity.
Materias (normalizadas)
Diabesity
Metabolic diseases
Palabras Clave
Adipose tissue
Carotid body
Catecholaminergic signaling
Energy expenditure
Sympathetic nervous system
Metabolic diseases
ISSN
1748-1708
Revisión por pares
SI
Patrocinador
Este trabajo forma parte del proyecto de investigación: "Horizons Europe PASGRAS project (ref 101080329) (Grant number(s): 101080329); JFS, FOM are supported with contracts from the Portuguese foundation for Science and Technology, CEEC IND/02428/2018 and CEECIND/04266/2017; ANR grant # 21-CE18-0016 (Grant number(s): 21-CE18-0016); FU2015-70616-R (MINECO/FEDER; DGICYT (Grant number(s): FU2015-70616-R); European Federation for the study of diabetes; Research Unit UID/04462: iNOVA4Health - Programa de Medicina Translacional, by the Associated Laboratory LS4FUTURE (LA/P/0087/2020) (Grant number(s): LA/P/0087/2020); PhD Grant from the Portuguese foundation for Science and Technology (PD/BD/128336/2017 (Grant number(s): PD/BD/128336/2017); Portuguese Society of Diabetes"
Version del Editor
Propietario de los Derechos
© 2025 The Author(s)
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Aparece en las colecciones
Dateien zu dieser Ressource
Tamaño:
10.08Mb
Formato:
Adobe PDF
